Millipore expands in Missouri

Life science supplier Millipore is giving a $3.4 million boost to its St. Charles, Missouri facility, which is the headquarters for its drug discovery business unit. The company will add 60 more people to the current 187 headcount. "The...expansion will enable Millipore to keep pace with the growth of its worldwide drug discovery and development business, which provides products and services that help pharmaceutical and biotechnology companies discover, evaluate and develop drug candidates," the company said in a statement. Back in September Millipore announced plans to give itself a $1.6B makeover as life sciences supplier.

- take a look at Millipore's release

Suggested Articles

Levo Therapeutics’ lead program did not beat placebo in a phase 3 study of Prader-Willi syndrome, a genetic disorder that causes insatiable hunger.

Denali is partnering with Biogen on its Parkinson's disease program, netting a $560 million upfront fee and a $465 million investment.

In the first half of 2020, the regenerative medicine sector raised $10.7 billion, more than the total it raised in 2019.